Scottish CMO Symbiosis expands production with 1.2M investment
10 Oct 2024 //
FIERCE PHARMA
Symbiosis Acquires 20,000 sq.-ft. Building in Stirling, UK
08 Oct 2024 //
CONTRACTPHARMA
Scantox Group Acquires UK-based CRO Gentronix
09 Sep 2024 //
CONTRACT PHARMA
Symbiosis Strengthens Analytical Testing Capability
12 Jul 2022 //
CONTRACTPHARMA
Symbiosis Completes UK Research and Innovation Project
01 Apr 2022 //
CONTRACTPHARMA
Symbiosis Expands Capabilities with BSL-2 Manufacturing Upgrade
11 Jan 2022 //
CONTRACTPHARMA
PlateletBio announces $75.5M Series B to extend autoimmune cell therapy
04 Nov 2021 //
ENDPTS
SymBiosis Launches to Advance Extensive, Growing Biotherapeutics Innovations
26 Oct 2021 //
BUSINESSWIRE
Symbiosis Pharma to manufacture Modus’ sepsis treatment
12 Oct 2021 //
PHARMAFILE
Symbiosis Completes Successful MHRA Audit
16 Sep 2021 //
CONTRACTPHARMA
Symbiosis, AstraZeneca Sign Supply Agreement for Sterile Vaccine Manufacture
25 Jun 2020 //
PHARMTECH
AstraZeneca taps Scottish firm for tenth COVID-19 vaccine supply deal
25 Jun 2020 //
REUTERS
Symbiosis and AstraZeneca Sign Supply Agreement for Sterile Manufacture
23 Jun 2020 //
PRNEWSWIRE
Cobra Biologics & Symbiosis £1.9m Inovate from Innovate UK
01 Feb 2018 //
PRESS RELEASE
US biotechs driving growth at Scottish CMO
16 Feb 2016 //
CPHI ONLINE